ASBPW

Aspire Biopharma Holdings, Inc. Warrant

39 hedge funds and large institutions have $727K invested in Aspire Biopharma Holdings, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
4
Closed
3
Calls
$2.36M
Puts
Net Calls
+$2.36M
Net Calls Change
+$234K
Name Holding Trade Value Shares
Change
Shares
Change %
AC
1
Athos Capital
Hong Kong
$232K -$39.2K -3,616 -14%
PC
2
Periscope Capital
Ontario, Canada
$74.1K
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$53.2K
SCM
4
Saba Capital Management
New York
$49.9K
LA
5
Linden Advisors
New York
$44.6K
AA
6
AQR Arbitrage
Connecticut
$32.4K
HCM
7
Highbridge Capital Management
New York
$27.4K -$4.6K
SC
8
Sculptor Capital
New York
$24.8K
Verition Fund Management
9
Verition Fund Management
Connecticut
$21.6K
WAM
10
Wolverine Asset Management
Illinois
$20.4K
Barclays
11
Barclays
United Kingdom
$18K
TCA
12
Taconic Capital Advisors
New York
$15K
Nomura Holdings
13
Nomura Holdings
Japan
$10.9K
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$10K
SFM
15
Spartan Fund Management
Canada
$9.35K -$90 -1,804 -1%
CCM
16
Context Capital Management
California
$9K
RCM
17
Radcliffe Capital Management
Pennsylvania
$8.12K
SRCM
18
Sage Rock Capital Management
New York
$8.12K
PAMP
19
Polar Asset Management Partners
Ontario, Canada
$7.02K
LP
20
LMR Partners
United Kingdom
$6.34K
WA
21
Whitebox Advisors
Minnesota
$6.34K
HIM
22
HGC Investment Management
Ontario, Canada
$5.07K
KL
23
KIM LLC
Kansas
$5K
FSI
24
Flow State Investments
Illinois
$4.88K +$1.83K +36,168 +60%
CCM
25
CAAS Capital Management
New York
$3.8K